People: Astellas Pharma Inc (4503.T)
5,700JPY
20 May 2013
¥-130 (-2.23%)
¥5,750
¥5,820
¥5,830
¥5,690
2,654,900
2,020,716
¥6,010
¥3,020
Hatanaka, Yoshihiko
Brief Biography
Mr. Yoshihiko Hatanaka has been serving as President and Representative Director in Astellas Pharma Inc. since June 20, 2011. He previously served as Executive Officer and Senior Executive Officer in the Company, as well as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.
Basic Compensation
| Total Annual Compensation, | Long-Term Incentive Plans, | All Other, | Fiscal Year Total, |
|---|---|---|---|
| -- | -- | -- | -- |
Options Compensation
| Quantity | Market Value | |
|---|---|---|
| Excercisable | -- | -- |
| Unexercisable | -- | -- |
| Excercised | -- | -- |
| Name | Fiscal Year Total |
|---|---|
Masafumi Nogimori |
-- |
Yoshihiko Hatanaka |
-- |
Yasuo Ishii |
-- |
Masao Yoshida |
-- |
Yoshiro Miyokawa |
-- |
Yukihiko Sato |
-- |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
